Anna Backmark is an Associate Principal Scientist in the Cardiovascular division of Research & Early Development at AstraZeneca, where they lead a team focused on drug discovery and the development of oligonucleotide therapeutics. With a graduate degree in Biochemistry and substantial experience in molecular biology and assay development, Anna has contributed to various projects in cardiovascular bioscience, significantly advancing the understanding and treatment of cardiac conditions. Their career, which includes roles at NobelBiocare and extensive research at AstraZeneca, is marked by a commitment to improving patient outcomes through collaborative scientific efforts. Anna also holds a PhD, during which they studied human water channel proteins, further enhancing their expertise in the field.
This person is not in the org chart
This person is not in any teams
This person is not in any offices